AbCellera Biologics ABCL
NASDAQ ABCL
$11.61 -0.32 (-2.64%)
As of: Oct 20, 2026 · 12:56 PM EDT

AbCellera Biologics (ABCL) Other Non-Current Assets (2020 - 2026)

Updated

AbCellera Biologics (ABCL) posted Other Non-Current Assets of $62.1 million for Q2 2026, up 8.1% from $57.45 million a year earlier but down 10.2% from the prior quarter.

Analysis

AbCellera Biologics (ABCL) Other Non-Current Assets (2020 - 2026) Analysis & Trends

At the end of FY2025, AbCellera Biologics' Other Non-Current Assets came in at $51.95 million, down 46.2% from FY2024.

  • Annual Other Non-Current Assets shows a five-year compound annual growth rate of 44.0% (FY2020 to FY2025).
  • In prior years, AbCellera Biologics' Other Non-Current Assets was $96.54 million in FY2024 (+2.4%), $94.24 million in FY2023 (+103.4%), $46.33 million in FY2022 (+51.2%) and $30.64 million in FY2021 (+265.3%).
  • Quarterly Other Non-Current Assets has run from a low of $30.64 million in Q4 2021 to a high of $134.22 million in Q3 2024 over five years.
  • On a year-over-year basis, Other Non-Current Assets increased in four of the last eight quarters, with an average decline of 13.5%.
  • The strongest year-over-year quarter for Other Non-Current Assets in the past five years was Q1 2022, with growth of 354.4%; the weakest was Q3 2025, with a decline of 60.5%.
  • According to Business Quant data, Other Non-Current Assets for the three prior quarters was $69.14 million (Q1 2026), $51.95 million (Q4 2025) and $53.07 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,154.92 Bn 1,123.51 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 624.00 Bn 542.53 Bn 17.26 Bn 14.27 Bn
3 AbbVie 511.67 Bn 484.78 Bn 12.70 Bn 10.73 Bn
4 Merck 365.56 Bn 319.94 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 297.27 Bn 261.26 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 261.19 Bn 234.88 Bn 12.86 Bn -
7 Amgen 235.19 Bn 190.59 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 193.04 Bn 167.23 Bn 6.22 Bn 4.75 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 9.94 Bn
10 AbCellera Biologics 3.54 Bn 3.00 Bn - 62.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 62.10 Mn
Mar 31, 2026 69.14 Mn
Dec 31, 2025 51.95 Mn
Sep 30, 2025 53.07 Mn
Jun 30, 2025 57.45 Mn
Mar 31, 2025 61.56 Mn
Dec 31, 2024 123.84 Mn
Sep 30, 2024 134.22 Mn
Jun 30, 2024 112.51 Mn
Mar 31, 2024 104.93 Mn
Dec 31, 2023 121.54 Mn
Sep 30, 2023 105.69 Mn
Jun 30, 2023 138.45 Mn
Mar 31, 2023 114.85 Mn
Dec 31, 2022 74.43 Mn
Sep 30, 2022 77.18 Mn
Jun 30, 2022 70.67 Mn
Mar 31, 2022 69.33 Mn
Dec 31, 2021 55.64 Mn
Sep 30, 2021 31.62 Mn
API Access

AbCellera Biologics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ABCL&period=max&api_key=YOUR_API_KEY